Innovent Biologics Ownership

Innovent Biologics has a total of 1.53 Billion outstanding shares. 30% of Innovent Biologics outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in pink sheets such as Innovent Biologics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Innovent Biologics, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innovent Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.